Citations

Citations to this article as recorded by  

• Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24‐week, randomized, open‐label, multicenter trial
  So Ra Kim, Jun Hwa Hong, Sin Gon Kim, Soo‐Kyung Kim, Hyuk‐Sang Kwon, Jun Sung Moon, Jung Hwan Park, Jae Myung Yu, Bong‐Soo Cha, Byung‐Wan Lee
  Diabetes, Obesity and Metabolism.2026; 28(4): 3305.     CrossRef
• Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension
  Jun Sung Moon, Kyung-Ah Han, Jae Myung Yu, Jong Chul Won, Jun Goo Kang, Soojin Park, Cheol-Young Park
  Diabetes Research and Clinical Practice.2026; 236: 113272.     CrossRef
• Cardiometabolic 2.0: Redefining Cardiovascular Prevention Through SGLT-2 Inhibitors and GLP-1 Receptor Agonists
  Maria-Daniela Tanasescu, Andrei-Mihnea Rosu, Alexandru Minca, Maria-Mihaela Grigorie, Delia Timofte, Dorin Ionescu
  Life.2026; 16(5): 756.     CrossRef
• Contemporary Type 2 Diabetes Guidelines: Converging Evidence, Diverging Strategies, and the Position of the Korean Diabetes Association Framework
  Suk Kyeong Kim, Dong-Lim Kim, Keeho Song, Shinae Kang, Byung-Wan Lee, Jong Han Choi
  Endocrinology and Metabolism.2026; 41(3): 351.     CrossRef
• The effect of rapid improvement of blood glucose level on diabetic neuropathy in Korean people with diabetes mellitus
  Hun Jee Choe, Bo Kyung Koo, Yoon-Ho Hong, Nam Hoon Kim, Jun Sung Moon, Yong-ho Lee, Ho Chan Cho, Soo Heon Kwak, Soo Lim, Dong-Lim Kim, Tae Ho Kim, Sin Gon Kim, Min Kyong Moon
  Diabetes Research and Clinical Practice.2026; 238: 113388.     CrossRef
• Periodontal Procedure Intensity and Incident Tinnitus in Korean Adults: A Nationwide Cohort Study
  Yu-Rin Kim, Minkook Son, Seon-Rye Kim, Byung-Jun Cho
  Medicina.2026; 62(8): 1578.     CrossRef

Citations

Citations to this article as recorded by  

• Impact of smart watch mobile application on the risk treatment of type 2 diabetes mellitus (iSMART-DM)
  Min Kyoung Jang, Yun Kyung Cho, Jung Yoon Moon, Se Hee Min, Ju Hee Hwang, Chang Hee Jung
  Primary Care Diabetes.2026; 20(1): 47.     CrossRef
• Continuous Glucose Monitoring for Pancreatogenic Diabetes After Total Pancreatectomy
  Young Jae Cho, Inhyuck Lee, Yoon Soo Chae, Go‐Won Choi, Younsoo Seo, Youngmin Han, Hye‐sol Jung, Wooil Kwon, Joon Seong Park, Jin‐Young Jang
  Journal of Hepato-Biliary-Pancreatic Sciences.2026; 33(3): 208.     CrossRef
• Real‐World Evidence of Long‐Term Dulaglutide Use: Sustained Glycemic and Weight Improvements Beyond Three Years
  Hwi Seung Kim, Myung Jin Kim, Hee Sung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee
  Clinical Endocrinology.2026; 104(5): 453.     CrossRef
• Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial
  Seung‐Hwan Lee, Kyung Ah Han, Eun‐Gyoung Hong, Jun Goo Kang, Choon Hee Chung, Jong Chul Won, Eon Ju Jeon, Jung‐Hwan Cho, Ho Chan Cho, Sin Gon Kim, Eun Seok Kang, So Hun Kim, Hae Jin Kim, In‐Kyung Jeong, Sung Wan Chun, Young Min Cho
  Diabetes, Obesity and Metabolism.2026; 28(3): 2027.     CrossRef
• Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24‐week, randomized, open‐label, multicenter trial
  So Ra Kim, Jun Hwa Hong, Sin Gon Kim, Soo‐Kyung Kim, Hyuk‐Sang Kwon, Jun Sung Moon, Jung Hwan Park, Jae Myung Yu, Bong‐Soo Cha, Byung‐Wan Lee
  Diabetes, Obesity and Metabolism.2026; 28(4): 3305.     CrossRef
• Global, Regional, and National Estimates of Undiagnosed Diabetes in Adults: Findings From the 2025 IDF Diabetes Atlas
  Felix Teufel, Katherine Orgutsova, Irini Genitsaridi, Rodrigo M. Carrillo-Larco, Jithin Sam Varghese, Maja E. Marcus, Julian W. Sacre, Seyedeh Forough Sajjadi, Faraja Chiwanga, Jennifer Manne-Goehler, Jacqueline Seiglie, David Flood, Jessica Harding, Para
  Diabetes Care.2026; 49(3): 490.     CrossRef
• The relationship between fasting blood glucose, glycated hemoglobin, fructosamine, and depression in patients with type 2 diabetes mellitus in South Korea: a secondary analysis of the Korea National Health and Nutrition Examination Survey VIII-2 (2020) da
  Jeesun Lee
  Journal of Korean Biological Nursing Science.2026; 28(1): 96.     CrossRef
• Identification of sex-specific sarcopenia risk groups among older adults using decision tree modeling: a cross-sectional study based on the Korean National Health and Nutrition Examination Survey
  Hee Sun Kim, Seok Hee Jeong, Se Young Jang
  Journal of Korean Biological Nursing Science.2026; 28(1): 78.     CrossRef
• Exploring the dual benefits: acute and subacute toxicity, hypolipidemic, slimming and hypoglycemic effects of Moringa oleifera lam
  Hafida Kedaid, Ikram Toumi, Mohamed Kraimat, Abdelkader Adamou, Alla Eddine Mahamedi, Rabiha Mezerai, Alia Telli
  Protoplasma.2026;[Epub]     CrossRef
• Efficacy and Safety of Fixed‐Dose Combinations of Sitagliptin and Empagliflozin as Add‐On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double‐Blind, Multi‐Centre, Placebo‐Controlled, Phase III Trial
  Soo Lim, Tae Nyun Kim, Ji Oh Mok, Choon Hee Chung, You Cheol Hwang, Ho Chan Cho, Jong Chul Won, Eonju Jeon, Eun Seok Kang, Ki Young Lee, Chong Hwa Kim, Soo Heon Kwak, Cheol Young Park, Kang Seo Park, Sang Yong Kim, Jae Hyuk Lee, Soon Hee Lee, Dong Hyeok C
  Diabetes, Obesity and Metabolism.2026; 28(6): 4847.     CrossRef
• Integrating Pharmacists into CGM-Enabled Digital Diabetes Care: Advancing Personalized and Data-Driven Management
  Xiaoxiao Chen, Gyeong Eon Kim, Nam Ah Kim, Kwang Joon Kim
  Healthcare.2026; 14(8): 1019.     CrossRef
• Cardiovascular outcomes with thiazolidinediones and sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus undergoing peripheral artery revascularization
  Ji Woong Roh, Jimin Jeon, Joonsang Yoo, Minyoul Baik, Seok-Jae Heo, Deok-Kyu Cho, Jinkwon Kim
  Diabetes Research and Clinical Practice.2026; 236: 113281.     CrossRef
• Physical activity levels and HINT-8 health-related quality of life in Korean adults with diabetes: analysis of KNHANES 2019–2021
  Sung Hoon Jeong, You-Jung Choi, Gain Shin, Ja-Ho Leigh
  Quality of Life Research.2026;[Epub]     CrossRef
• Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension
  Jun Sung Moon, Kyung-Ah Han, Jae Myung Yu, Jong Chul Won, Jun Goo Kang, Soojin Park, Cheol-Young Park
  Diabetes Research and Clinical Practice.2026; 236: 113272.     CrossRef
• Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real‐World Observational Study
  Jaehyun Bae, Minyoung Lee, Hyung Woo Kim, Jung Tak Park, Seung Hyeok Han, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Tae‐Hyun Yoo, Yong‐ho Lee
  Diabetes, Obesity and Metabolism.2026; 28(7): 6245.     CrossRef
• Factors associated with glycemic control in Korean older adults with diabetes living alone: A secondary analysis
  Hee Jung Kim, Sun Ju Chang, Yujin Park, Joo Ri Kim, Yeon Woo Jung, Gi Won Choi
  Journal of Korean Gerontological Nursing.2026; 28(2): 148.     CrossRef
• The National Health Insurance Support System for Diabetes Consumables and Management Devices in South Korea: Status, Challenges, and Policy Directions
  Okha Ryu, Yo Han Lee
  Health Insurance Review & Assessment Service Research.2026; 6(1): 46.     CrossRef
• Intermittent Fasting and Risk of Diabetic Retinopathy: Retrospective Data from the National Health and Nutrition Examination Survey
  Sejeong Lee, Youngjoon Kim, Min Heui Yu, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Soo-Hyun Park, Sungha Park, Min Kim, Christopher Seungkyu Lee, Eun Young Choi, Minyoung Lee
  Nutrients.2026; 18(11): 1696.     CrossRef
• Nanoscale lipid methylprednisolone conjugates: Synthesis, characterization, and therapeutic efficacy in retinal pigment epithelial cells inflammation
  Aqsa Arif, Saadat Hussain, Rabbia Muneer, Perveen Bano, Haroon Tayyab, Karim F. Damji, Irfan Khan, Mujeeb ur Rehman
  Journal of Drug Delivery Science and Technology.2026; 124: 108608.     CrossRef
• Association of healthy lifestyle and dietary practices with prediabetes among young Korean adults: sex-specific findings from KNHANES 2020–2024
  Youngmi Lee, Sooyoun Kwon, Heejung Park, Jean Kyung Paik, Hee-Sook Lim, Yoo Kyoung Park, Yun-Jung Bae
  Nutrition Research and Practice.2026; 20(3): 539.     CrossRef
• Utilization of glycated hemoglobin testing in the Korean health check-up population from local clinics and hospitals and its impact on diabetes and prediabetes classification
  Rihwa Choi, Mi-Jung Park, Sang Gon Lee
  BMC Endocrine Disorders.2026;[Epub]     CrossRef
• Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Mental Health Disorders in Type 2 Diabetes: Active Comparator, New User Cohort Study
  Chungsoo Kim, Seonji Kim, Dong Yun Lee, Eugene Han, Yong‐ho Lee, Seng Chan You
  Diabetes, Obesity and Metabolism.2026; 28(9): 8482.     CrossRef
• Impact of initial severity and progression pattern of new-onset diabetes on pancreatic cancer risk: a 15-year longitudinal nationwide cohort study
  Minyoung Lee, Min Heui Yu, Wonjeong Chae, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sung-in Jang, Moon Jae Chung
  Gut.2026; : gutjnl-2025-335863.     CrossRef
• Circulating GDF15 levels reflect metabolic and inflammatory burden in early dysglycemia: findings from the ADIOS cohort
  Ji Yoon Kim, Ah Hyeon Lee, Jiyoon Lee, Hye-Min Jang, Sin Gon Kim, Dong-Hoon Kim, Nam Hoon Kim
  Diabetes Research and Clinical Practice.2026; 239: 113461.     CrossRef
• Cardiovascular Risk Factor Prevalence and Control by Education Strata in Older Adults in 3 Countries
  Ralph Lawton, David M. Cutler
  JAMA Network Open.2026; 9(7): e2625410.     CrossRef
• Lower glucagon response and attenuated hepatic glucagon signaling in MASLD
  So Ra Kim, Yeseong Hwang, Minyoung Lee, Arim Choi, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Kwang Joon Kim, Yong-ho Lee
  Diabetes & Metabolism.2026; 52(5): 101787.     CrossRef
• Diabetes-related foot disease in the Western Pacific: foot burdens, care and strategies across the region
  Byron M. Perrin, Susanna M. Cramb, Sadhana Chandrasekar, Vivienne H. Chuter, Robert Fitridge, Michele Garrett, Zhiwen Joseph Lo, Kavita Venkataraman, Nobuyoshi Azuma, Charles R. Cabuquit, James Charles, Heidi Corcoran, Nicoletta Frescos, Emma J. Hamilton,
  The Lancet Regional Health - Western Pacific.2026; : 101960.     CrossRef
• Effect of insulin sensitivity and secretion defects at mid-pregnancy on early postpartum glucose intolerance in women with gestational diabetes mellitus
  Kyung-Soo Kim, Arim Choi, Hyunju Park, Soo-Kyung Kim, Yong-Wook Cho
  Frontiers in Endocrinology.2026;[Epub]     CrossRef
• Age-Specific Behavioral and Clinical Risk Factors for Diabetes, Hypertension, and Hypercholesterolemia
  Yujung Lee, Soobin Jang, Bo-Hyoung Jang, Chunhoo Cheon
  Journal of Nutrition Education and Behavior.2026;[Epub]     CrossRef
• Glucagon-like Peptide-1 Receptor Agonists and Gastrointestinal Neoplasms
  Yu Jin Kim, Jaehyun Bae
  Journal of Digestive Cancer Research.2025; 13(2): 99.     CrossRef
• Is the next STEP on the BPROAD to intensive blood pressure lowering for all type 2 diabetic patients?: consensus statements from the Korean Society of Hypertension
  Eun Mi Lee, In-Jeong Cho, Hae Jin Kim, Dae-Hee Kim, Hae-Young Lee, Sungha Park, Sang-Hyun Ihm
  Clinical Hypertension.2025;[Epub]     CrossRef
• Lifestyle prescriptions for diabetes management in primary care: a narrative review
  Hye Jun Lee, Jung-Ha Kim
  Ewha Medical Journal.2025; 48(4): e55.     CrossRef
• Obesity Pharmacotherapy: A Practical Approach to Patient-Centered Medication Selection
  Jungha Park
  Korean Journal of Family Practice.2025; 15(4): 194.     CrossRef
• Genetic Variants in HTR3B Locus Influence Glycemic Control and Type 2 Diabetes Susceptibility in Koreans
  Sangwook Park
  Biomedical Science Letters.2025; 31(4): 364.     CrossRef
• Optimising HbA1c monitoring intervals in patients with type 2 diabetes based on glycaemic control status: a target trial emulation study
  Boyuan Wang, Emily Tsui Yee Tse, Shugang Li, Hao Wu, Celine Sze Ling Chui, Cindy Lo Kuen Lam, Eric Yuk Fai Wan
  BJGP Open.2025; : BJGPO.2025.0020.     CrossRef

Citations

Citations to this article as recorded by  

• Comparison of diagnostic criteria for fatty liver disease in assessing cardiac dysfunction: a cross-sectional study
  Yun Kyung Cho, Myung Jin Kim, Eun Hee Kim, Min Jung Lee, Hyo-Jung Nam, Woo Je Lee, Hong-Kyu Kim, Chang Hee Jung
  Hepatology International.2026; 20(1): 81.     CrossRef
• Biological determinants and outcomes of sex discrepancies in MASLD
  Amedeo Lonardo, Mohamad Jamalinia, Ralf Weiskirchen
  Metabolism and Target Organ Damage.2026;[Epub]     CrossRef
• Mazdutide Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Endoplasmic Reticulum Stress, Improving Lipid Metabolism and Alleviating Inflammation
  Liangyu Gan, Lengxin Duan, Xueyi Zheng
  Pharmaceuticals.2026; 19(3): 371.     CrossRef
• Special Population
  Janus P. Ong, Hasmik Ghazinyan, Vincent Wai-Sun Wong, Yuichiro Eguchi
  Clinics in Liver Disease.2026; 30(2): 435.     CrossRef
• Managing Metabolic Dysfunction–Associated Steatotic Liver Disease: Protocol for a Scoping Review of Patient Perceptions, Barriers, and Facilitators
  Sikyeong Park, Yu Shin Park, Dahye Hong, Bada Kang
  JMIR Research Protocols.2026; 15: e81404.     CrossRef
• Association between the Zhejiang University index and metabolic dysfunction-associated fatty liver disease as analyzed in National Health and Nutrition Examination Survey: A retrospective observational study
  Wei Fu, Xiaoyue Wu, Guobin Cheng, Linya Lyu, Hulin Wang
  Journal of International Medical Research.2026;[Epub]     CrossRef
• Aqueous Extract of Siraitia grosvenorii Alleviates MAFLD by Modulating Metabolism and Maintaining Gut Homeostasis in High-Fat Diet Fed Mice
  Hong Li, Zhongzhen Zhao, Yiming Ding, Weixian Shao, Yu Zhou, Junxiu Li, Zailin Liang, Bin Peng, Fusheng Mo, Jiao Zheng, Shengli Wei, Yuan Zhang
  Foods.2026; 15(7): 1241.     CrossRef
• Associations of body roundness index with steatotic liver disease and mortality from the UK biobank cohort study
  Jinyoung Shin, Seok-Jae Heo, Yae-Ji Lee, Yu-Jin Kwon, Ji-Won Lee
  BMC Gastroenterology.2026;[Epub]     CrossRef
• Income Persistence and the Risk of Hepatocellular Carcinoma in Individuals with Type 2 Diabetes
  Jong-Ha Baek, Yong-Moon Mark Park, Benjamin C. Amick, Mario Schootman, Michael R. Thomsen, Oak-Kee Hong, Seung-Hyun Ko, Clare C. Brown, Marie-Rachelle Narcisse, Pearl A. McElfish, Seong-Su Lee, Kyungdo Han
  Cancer Epidemiology, Biomarkers & Prevention.2026; 35(5): 743.     CrossRef
• Current Trends and Perspectives on Obesity and Metabolic Dysfunction-Associated Steatohepatitis in East Asia
  Soo Lim, Hui Zhou, Wataru Ogawa
  Journal of Obesity & Metabolic Syndrome.2026; 35(2): 130.     CrossRef
• DN203316, a novel PPARδ agonist, suppresses ferroptotic signaling and fibrogenesis in metabolic dysfunction-associated steatohepatitis
  Ye Jin Kim, Jina Kim, Da Young An, Mihyang Park, Gui-Hwa Jeong, Jonghwa Jin, Mi Kyung Kim, Jungwook Chin, Yeon-Kyung Choi, Keun-Gyu Park
  Experimental & Molecular Medicine.2026; 58(6): 1900.     CrossRef
• Association between the triglyceride-glycated hemoglobin index and diabetes risk among patients with Non-alcoholic fatty liver disease: A longitudinal cohort study
  Cuimei Wei, Changchun Cao, Zengxin Xu, Gang Chen, Wenjing Liu, Miao Zhang, Haofei Hu, Shanghua Xu, Aleksandra Klisic
  PLOS One.2026; 21(6): e0350633.     CrossRef
• Bioelectrical impedance analysis parameters are superior to liver enzymes in predicting metabolic dysfunction-associated steatotic liver disease in young adults
  Kyungchul Song, Yu-Jin Kwon, Eunju Lee, Hye Sun Lee, Young Hoon Youn, Su Jung Baik, Hana Lee, Joon Young Kim, Youngha Choi, Hyun Wook Chae
  Internal and Emergency Medicine.2025; 20(3): 785.     CrossRef
• Extracellular Vesicle-Mediated Network in the Pathogenesis of Obesity, Diabetes, Steatotic Liver Disease, and Cardiovascular Disease
  Joonyub Lee, Won Gun Choi, Marie Rhee, Seung-Hwan Lee
  Diabetes & Metabolism Journal.2025; 49(3): 348.     CrossRef
• SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application
  Jae Hyun Bae
  Diabetes & Metabolism Journal.2025; 49(3): 386.     CrossRef
• Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality
  Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park
  Cardiovascular Diabetology.2025;[Epub]     CrossRef
• Development of a simple metabolic score to predict liver fibrosis risk in chronic hepatitis B patients: A retrospective cross-sectional study
  Li Liu, Peng Ye, Qiuping Gu, Ling Zeng, Lijuan Liang, Yingfeng Wei
  Journal of International Medical Research.2025;[Epub]     CrossRef
• 2025 Clinical Practice Guidelines for Diabetes: Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
  Jaehyun Bae
  The Journal of Korean Diabetes.2025; 26(3): 172.     CrossRef
• Research trends on the quality of life in patients with metabolic dysfunction-associated fatty liver diseases: a scientific metrology study
  Can Huang, Meng Chen, Yanfang Sun, Lin Zhang, Wei Liu
  Frontiers in Nutrition.2025;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Efficacy and Safety of Stage 5 Connected Insulin Pens in Type 1 or Type 2 Diabetes: Randomized Controlled Trial Protocol (SMART-5 Study)
  Ji Yoon Kim, Nam Hoon Kim, Soo Heon Kwak, Chang Hee Jung, Eun Seok Kang, Jun Sung Moon, Sun Joon Moon, So Yoon Kwon, Jee Hee Yoo, Younghoon Kim, Tae-min Lee, Chung-il Yang, Jae Hyeon Kim, Sang-Man Jin
  Endocrinology and Metabolism.2026; 41(3): 393.     CrossRef
• Novel metabolic syndrome subgroups and their association with cardiovascular outcomes: A data‐driven cluster analysis of the UK Biobank
  Yongin Cho, Hye‐Sun Park, Dae Hyung Lee, Young Ju Suh, Jong Ho Jhee, Jong Hyun Jhee, So Hun Kim
  Diabetes, Obesity and Metabolism.2026; 28(3): 2286.     CrossRef
• Long-term effectiveness on glycemic control of insulin compared to combined oral antidiabetic drugs for initial intensive treatment in newly diagnosed type 2 diabetes: A duplicated target trial
  Tae Hyeon Kim, Yerin Hwang, Selin Woo, Kyeongmin Lee, Yejun Son, Seoyoung Park, Hyunjee Kim, Ju-Young Shin, YongHyun Cho, Dahye Shin, Dosang Cho, Kyung-Jae Lee, Sang Youl Rhee, Dong Keon Yon
  Medicine.2026; 105(5): e47235.     CrossRef
• Systematic Survey of Guidelines With Recommendations Related to Concordant Multimorbidity: Diabetes, Coronary Heart Disease and Stroke as an Example
  Zijun Wang, Jie Zhang, Bingyi Wang, Huayu Zhang, Ling Wang, Zhewei Li, Di Zhu, Hongfeng He, Luyuan Sun, Xuefeng Li, Sheyu Li, Yaolong Chen, Janne Estill
  Journal of Evaluation in Clinical Practice.2026;[Epub]     CrossRef
• Continuous glucose monitoring and risks of acute and chronic diabetes-related complications and mortality in adults with type 1 diabetes: a nationwide cohort study
  Ji Yoon Kim, Seohyun Kim, Jae Hyeon Kim
  Diabetologia.2026; 69(7): 1858.     CrossRef
• Association between long-term air pollutant exposure and blood pressure and hypertension: A stratified analysis based on vitamin D status
  Su Jin Kim, Jae Moon Yun, Su Hwan Cho, Soontae Kim, Yoon-Hee Kang, Hyun-Jin Kim, Jin Ho Park
  Environmental Pollution.2026; 397: 127935.     CrossRef
• Diabetes Fact Sheet 2025: Comparative Epidemiology and Clinical Features of Obese and Non-Obese Diabetes in Korea
  Jin Hwa Kim, Bongseong Kim, Se Eun Park, Seung-Hyun Ko, Sung Hee Choi, Bong Soo Cha, Kyungdo Han, Seung-Hwan Lee
  Diabetes & Metabolism Journal.2026; 50(2): 267.     CrossRef
• Glucose control and mortality from lower respiratory tract infections in patients with diabetes: evidence from real-world data
  Youngmin Shin, Sang Jun Eun, Ju-Mi Lee
  BMC Infectious Diseases.2026;[Epub]     CrossRef
• Associations of Regular Participation in Aerobic and Resistance Exercise with Metabolic Health Indicators and Type 2 Diabetes Risk: A Cross-Sectional Analysis of the 2023 Korea National Health and Nutrition Examination Survey
  Yun-Sung Kim, Young-Min Park, Dong-il Kim
  Exercise Science.2026; 35(1): 41.     CrossRef
• Structural and Functional Properties of Ingredient Composition in Kenkey Preparation: A Review
  Afia Sakyiwaa Amponsah
  ChemFoodChem.2026;[Epub]     CrossRef
• Developmental Toxicity of n‐Butanol in Chick Embryos: Dose‐Dependent Effects on Morphology, Behavior, Oxidative Stress, Tissue Integrity, and Post‐Hatching Feeding and Locomotor Behavior Disruption Induced by n‐Butanol
  Hina Shabir, Shazia Perveen, Imran Haider, Sumaira Kanwal, Ahmed O. Abbas, Hesham Hassanien, Abdallah T. Mansour, Mohamed Ashour
  Journal of Applied Toxicology.2026;[Epub]     CrossRef
• Association Between SGLT2 Inhibitors and DPP‐4 Inhibitors Use and Risk of Acute Pancreatitis: Findings From Nationwide Case‐Based Analyses
  Ye‐Jee Kim, Yun Kyung Cho, Mi‐Sook Kim, Joongyub Lee, Seonghae Kim, Bo Ram Yang
  Diabetes, Obesity and Metabolism.2026; 28(8): 6767.     CrossRef
• Sodium-glucose cotransporter 2 inhibitors and the risk of kidney cancer among patients with type 2 diabetes: a population-based cohort study
  Minyoung Lee, Hokyou Lee, Eun-Jin Kim, Dasom Son, Hyeok-Hee Lee, Hyeon Chang Kim, Eun Seok Kang
  BMC Medicine.2026;[Epub]     CrossRef
• Continuous Glucose Monitoring-Informed Basal Insulin Optimization System in Adults with Type 2 Diabetes: Initial Evaluation of Efficacy, Safety, and Impact on Patient-Reported Outcomes
  Sean M. Oser, Chad Crystal, Kazanna C. Hames, Xuan Li, Peggy Gao, Margaret A. Crawford, Christian Hicks, Matthew Gerber, Thibault Gautier, Patricio Colmegna, Lei Yang, Harsimran Singh, Matthew L. Johnson, Stayce E. Beck
  Diabetes Therapy.2026;[Epub]     CrossRef
• Data-Driven Multidimensional Clinical Phenotypes and Longitudinal Changes in Type 2 Diabetes Mellitus: A Retrospective Cohort Study
  Andreea Diana Igna, Bianca-Lăcrimioara Petca, Paula-Alexandra Popovici, Timea Claudia Ghitea, Mihaela Simona Popoviciu
  Biomedicines.2026; 14(9): 1903.     CrossRef
• Multidomain Cardiorenal-Metabolic Abnormalities Despite HbA1c <7% in Type 2 Diabetes: A Real-World Observational Study
  Igna Andreea Diana, Petca Bianca-Lăcrimioara, Popovici Paula-Alexandra, Timea Claudia Ghitea, Roxana Daniela Brata, Daniela Florina Trifan, Mihaela Simona Popoviciu
  Diseases.2026; 14(9): 329.     CrossRef
• Pharmacological management of diabetes in older adults
  Junghyun Noh
  Cardiovascular Prevention and Pharmacotherapy.2025; 7(1): 13.     CrossRef
• Effects of e-health literacy on health-related quality of life in young adults with type 2 diabetes: Parallel mediation of diabetes self-efficacy and self-care behaviors
  Yura Jang, Youngran Yang
  Applied Nursing Research.2025; 82: 151917.     CrossRef
• Prevalence, Incidence, and Metabolic Characteristics of Young Adults with Type 2 Diabetes Mellitus in South Korea (2010–2020)
  Ji Yoon Kim, Jiyoon Lee, Joon Ho Moon, Se Eun Park, Seung-Hyun Ko, Sung Hee Choi, Nam Hoon Kim
  Diabetes & Metabolism Journal.2025; 49(2): 172.     CrossRef
• Workplace‐based continuous glucose monitoring with structured education for pre‐diabetes and type 2 diabetes: A prospective community cohort study
  Ji‐Hee Ko, Sun‐Joon Moon, Ramzi A. Ajjan, Mi Yeon Lee, Hae‐Jeong Lee, Boram Choi, JiYeon Park, Seung‐Eun Lee, Jae‐Hyeon Kang, Cheol‐Young Park
  Diabetes, Obesity and Metabolism.2025; 27(6): 2996.     CrossRef
• Multidisciplinary Care Model as a Center of Excellence for Fabry Disease: A Practical Guide to Diagnosis and Management by Clinical Specialty in South Korea
  Soo Yong Lee, Il Young Kim, Sung-Ho Ahn, Su Jin Kim, Hyun-Min Lee, Ji Eun Lee, Gyeong-Jo Byeon, Hyun-Chang Ko, Hyun Jung Lee, Songhwa Choi, Chong Kun Cheon
  Journal of Clinical Medicine.2025; 14(13): 4400.     CrossRef
• The Effect of Frailty on Body Composition and Its Impact on the Use of SGLT-2 Inhibitors and GLP-1RA in Older Persons with Diabetes
  Alan Sinclair, Izel Siqueira, Ahmed Abdelhafiz
  Metabolites.2025; 15(6): 381.     CrossRef
• Feasibility of a Structured Calorie-Restricted Dietary Intervention in Korean Adults with Early Type 2 Diabetes and Obesity: A Pilot Study
  Su-Jeong Park, Mee Kyung Kim, Jinyoung Kim, Ji-Yeon Choi, YoonJu Song, Hyuk-Sang Kwon
  Nutrients.2025; 17(9): 1530.     CrossRef
• Cardiorenal outcomes and safety of SGLT2 inhibitors in patients with diabetes secondary to disorders of the exocrine pancreas: a nationwide population-based study
  Kyoung Hwa Ha, Minae Park, Yujin Lee, Dae Jung Kim, Seung Jin Han
  Diabetes & Metabolism.2025; 51(5): 101668.     CrossRef
• How Do We Diagnose Diabetes in Primary Care?
  Hyeong Jin Kim
  The Journal of Korean Diabetes.2025; 26(1): 10.     CrossRef
• Associations of time in tight range, time in range, and glycated hemoglobin with albuminuria in type 1 diabetes: A cross-sectional study
  Ji Yoon Kim, Seohyun Kim, Sang Ho Park, Jin A Lee, So Hyun Cho, Rosa Oh, Myunghwa Jang, You-Bin Lee, Gyuri Kim, Kyu Yeon Hur, Jae Hyeon Kim, Sang-Man Jin
  Diabetes Research and Clinical Practice.2025; 226: 112325.     CrossRef
• Diabetes medication management recommendations for older adults: A systematic review of the Western Pacific region
  Darshna Goordeen, J Simon Bell, Youmna Elsedfy, Soroush Fariman, Shota Hamada, Yukari Hattori, Kate Wang, Majd Abu Al Shieh, Michael Nunan, Joshua D Niznik, Emily Reeve
  Geriatrics & Gerontology International.2025; 25(6): 717.     CrossRef
• Medical Nutrition Therapy as a Hospital-Based Lifestyle Modification in the Korean Diabetes Prevention Study
  Ji Hye Choi, Jung-Hwa Lee, Suk Chon
  The Journal of Korean Diabetes.2025; 26(1): 39.     CrossRef
• Impact of physical activities in metabolic dysfunction associated steatotic liver disease, sarcopenia, and cardiovascular disease
  Eugene Han, Sin Yung Woo, Justin Y. Jeon, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee, Yong-ho Lee
  Diabetes Research and Clinical Practice.2025; 224: 112209.     CrossRef
• Optimal Management of Diabetic Kidney Disease
  Jae-Han Jeon
  The Journal of Korean Diabetes.2025; 26(1): 1.     CrossRef
• Clinical Characteristics and Epidemiology of Cardiovascular Autonomic Neuropathy in Peoples With Long-Standing Diabetes
  Sook Jung Lee, Chong Hwa Kim, Su Jin Jeong, Jae-Seung Yun, Jong Chul Won, Jae Hyuk Lee, Ie Byung Park, Chang Won Lee, Hyuk-Sang Kwon, Tae Sun Park
  Journal of Korean Medical Science.2025;[Epub]     CrossRef
• Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function
  Ji-Hyun Kim, Seung-Hwan Lee, Kyu Na Lee, Kyungdo Han, Mee Kyoung Kim
  Journal of Lipid and Atherosclerosis.2025; 14(2): 190.     CrossRef
• Recovery time of diabetic ketoacidosis in Africa: Systematic review and meta-analysis
  Tadios Lidetu, Simon Birhanu, Addisu Simachew Asgai, Tsegaamlak Kumelachew Derse, Yideg Abinew, Moges Tadesse, Desalegn Mitiku, Jemberu Chane, Banchamilak Adane, Tadele Kassahun Wudu, Betelhem Mekonnen, Desiyalew Habtamu Tamiru
  Metabolism Open.2025; 26: 100370.     CrossRef
• The utility of common predictive models for detecting undiagnosed diabetes and prediabetes defined by HbA1c in a Chinese population
  Shuqi Wang, Benjamin H.K. Yip, Paul K.M. Poon, Billy C.F. Chiu, Samuel Y.S. Wong, Juliana C.N. Chan, Eric K.P. Lee
  Diabetes Research and Clinical Practice.2025; 226: 112344.     CrossRef
• Advances in Continuous Glucose Monitoring: Clinical Applications
  So Yoon Kwon, Jun Sung Moon
  Endocrinology and Metabolism.2025; 40(2): 161.     CrossRef
• Differences between Type 2 Diabetes Mellitus and Obesity Management: Medical, Social, and Public Health Perspectives
  Soo Lim, Ga Eun Nam, Arya M. Sharma
  Diabetes & Metabolism Journal.2025; 49(4): 565.     CrossRef
• De-escalation, palliation and end of life care in frail older people with diabetes-a critical review
  I. Siqueira, J. Jenkinson, P. Briggs, H. Picker, X. Chen, A. H. Abdelhafiz
  Expert Review of Endocrinology & Metabolism.2025; 20(6): 593.     CrossRef
• Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality
  Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park
  Cardiovascular Diabetology.2025;[Epub]     CrossRef
• Associations between Diabetes, Diabetes Duration, and Psychiatric Difficulties: A Nationwide Cross-sectional Study
  Young-Chan Kim, Kyungdo Han, Suhyung Kim, Yoo Hyun Um, Tae-Won Kim, Ho Jun Seo, Seung-Chul Hong, Jong-Hyun Jeong
  Clinical Psychopharmacology and Neuroscience.2025; 23(3): 476.     CrossRef
• Fenofibrate therapy and risk of heart failure outcomes in patients with Type 2 diabetes: a propensity-matched cohort study
  Ji Yoon Kim, Nam Hoon Kim, Jiyoon Lee, Dong-Hoon Kim, Sin Gon Kim
  European Heart Journal - Cardiovascular Pharmacotherapy.2025; 11(7): 620.     CrossRef
• Effects of Pilates exercise on glycated hemoglobin and fasting blood sugar in type 2 diabetes: a systematic review and meta-analysis
  Se-Na Yu, Hee-Jin Moon, Myung-Haeng Hur
  Journal of Korean Biological Nursing Science.2025; 27(3): 317.     CrossRef
• Efficacy and safety in tirzepatide‐treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS‐AP‐combo and SURPASS‐3
  Byung Wan Lee, Chang Beom Lee, Soo Lim, Sin Gon Kim, Nan Hee Kim, Jong Chul Won, Woo Je Lee, Min Ju Kang, Ju Young Yuh, Li Ying Du, Hyojin Lim, Kyu Jeung Ahn
  Diabetes, Obesity and Metabolism.2025; 27(12): 7110.     CrossRef
• Insulin resistance and the risk of incident depression: the role of age, glycemic status, and adiposity in a prospective cohort study
  Dae Jong Oh, Chaiho Jeong, Junhyung Kim, Eun Soo Kim, Kang-Seob Oh, Young Chul Shin, Dong-Won Shin, Sang-Won Jeon, Sung Joon Cho
  The Lancet Regional Health - Western Pacific.2025; 62: 101672.     CrossRef
• Cardiometabolic and renal benefits of sodium–glucose cotransporter 2 inhibitors
  Yong-ho Lee, Soo Lim, Melanie J. Davies
  Nature Reviews Endocrinology.2025; 21(12): 783.     CrossRef
• Physical activity for prevention of cardiovascular disease: consensus statement of Korean Society of Cardio-cerebrovascular Disease Prevention
  Ye Seul Yang, Eu Jeong Ku, Seung-Hyun Ko, Eun-Jung Rhee, Sang-Hyun Ihm, Sung Hee Choi, Won-Young Lee
  The Korean Journal of Internal Medicine.2025; 40(5): 696.     CrossRef
• Nutriomics and artificial intelligence nutrition obesity cohort (NAINOC): a design paper for a prospective cohort for nutrition and obesity research
  Minyoung Lee, Sungha Park, Soo-Hyun Park, Ho-Young Park, Yu Ra Lee, Min-Sun Kim, Miso Nam, Jangho Lee, Hyein Seo, Yong-ho Lee, Chan Joo Lee, Jae-Ho Park, Hye Hyun Yoo, Hyun-Jin Kim, Kyong-Oh Shin, Yoshikazu Uchida, Kyungho Park
  Clinical Hypertension.2025;[Epub]     CrossRef
• 2025 Clinical Practice Guidelines for Diabetes: Pharmacological Treatment of Type 2 Diabetes
  Jong Han Choi
  The Journal of Korean Diabetes.2025; 26(3): 158.     CrossRef
• Trends and differences in cardiovascular disease and alzheimer's disease-related mortality among older adults in the United States, 1999 to 2023: A CDC WONDER database analysis
  Jianren Wen, Jingxuan Hu, Guohui Zou
  American Heart Journal Plus: Cardiology Research and Practice.2025; 59: 100618.     CrossRef
• Association between alpha-lipoic acid use and macrovascular complications in patients with diabetic neuropathy
  Yongin Cho, Hye-Sun Park, Hye Sun Lee, Hyejin Yang, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, So Hun Kim
  Endocrine.2025; 90(3): 1233.     CrossRef
• The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes
  Jaehyun Bae, Minyoung Lee, Yong-ho Lee, Sang-Guk Lee, Byung-Wan Lee
  International Journal of Molecular Sciences.2025; 26(17): 8566.     CrossRef
• The effect of dioxin exposure on diabetes and potential dietary modification in the Korean population
  Youngmin Han, Keum Ji Jung, Young Wook Lim, Yong Jin Lee, Youn Seok Kang, Sun Ha Jee
  Endocrine.2025; 90(3): 1275.     CrossRef
• 2025 Clinical Practice Guidelines for Diabetes: Cardiovascular Risk Management
  Hae Jin Kim
  The Journal of Korean Diabetes.2025; 26(3): 164.     CrossRef
• Bone Health in Type 1 and Type 2 Diabetes: Pathophysiological Mechanisms, Clinical Implications, and Management Strategies
  Hermine Carine Pouabe Epse Bodah, Suraiya Rahman Shifa, Sara Saleh, Tuba Abeer Hashmi, Tuleen Al Shawa, Badreshiya Kajal Akshaykumar, Nabeel Sufwan, Rajvinder Kaur, Andrii Shevchuk, Usman Ul Haq, Manju Rai
  SN Comprehensive Clinical Medicine.2025;[Epub]     CrossRef
• Dietary Interventions for Adults with Type 1 Diabetes: Clinical Outcomes, Guideline Alignment, and Research Gaps—A Scoping Review
  Beata Małgorzata Sperkowska, Agnieszka Chrustek, Anna Gryn-Rynko, Anna Proszowska
  Nutrients.2025; 17(21): 3349.     CrossRef
• Managing hypertension, diabetes, and dyslipidemia in frail older adults
  Jung-Yeon Choi, Cheol-Ho Kim, Kwang-il Kim
  Cardiovascular Prevention and Pharmacotherapy.2025; 7(4): 135.     CrossRef
• Physical activity for prevention of cardiovascular disease: a consensus statement of the Korean Society of Cardio-cerebrovascular Disease Prevention
  Ye Seul Yang, Eu Jeong Ku, Seung-Hyun Ko, Eun-Jung Rhee, Sang-Hyun Ihm, Sung Hee Choi, Won-Young Lee
  Cardiovascular Prevention and Pharmacotherapy.2025; 7(4): 120.     CrossRef
• Current Status of Delay in Injectable Therapy among Type 2 Diabetes Mellitus Patients in South Korea: Multicenter Retrospective Study (2015–2021)
  Jong Han Choi, Min Kyong Moon, Hae Jin Kim, Kyung Ae Lee, Hyun Jin Kim, Jung Hae Ko, Jae-Seung Yun, Seung-Hyun Ko, Suk Chon, Nam Hoon Kim
  Endocrinology and Metabolism.2025; 40(5): 727.     CrossRef
• Impact of national reimbursement policy supporting test strips on glycemic control in people with insulin-treated diabetes: retrospective cohort study
  Seohyun Kim, Mira Kang, Dohyun Park, Gyuri Kim, Jae Hyeon Kim
  BMC Public Health.2025;[Epub]     CrossRef
• Beta-Cell Function, Insulin Sensitivity, and Metabolic Characteristics in Young-Onset Type 2 Diabetes Mellitus: Findings from Anam Diabetes Observational Study
  Ji Yoon Kim, Jiyoon Lee, Sin Gon Kim, Nam Hoon Kim
  Diabetes & Metabolism Journal.2025; 49(6): 1287.     CrossRef
• Efficacy and safety of pioglitazone versus dapagliflozin as an add-on to metformin and alogliptin combination therapy: the EPIDOTE study
  Kyuho Kim, Seung-Hyun Ko, Jae-Seung Yun, Kwan-Woo Lee, Eun Sook Kim, In-Kyung Jeong, Jae Hyeon Kim, Sang Yong Kim, Kyu Chang Won, Mikyung Kim, Bong-Soo Cha, Sungrae Kim, Sung Hee Choi, Eun-Jung Rhee, Sin Gon Kim, Bo Hyun Kim, Kang Seo Park, Young-Cheol Ju
  Scientific Reports.2025;[Epub]     CrossRef
• A novel clinical biomarker-based Physiology Healthy Aging Index and risk of all-cause and cause-specific mortality: A 20-year prospective cohort study
  Jieun Lyu, Ji-Yun Hwang, Joong-Yeon Lim, Yoon Jung Park
  GeroScience.2025;[Epub]     CrossRef
• Clinical Considerations in Managing Obesity and Obesity-Related Comorbidities
  Hyojin Park, Sun Hyun Kim
  Korean Journal of Family Practice.2025; 15(4): 186.     CrossRef
• Review for Chinese Medicine-Specific Health Management in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus
  Rui Yao, Cuixia Lin, Shuang Lin, Yanhui Yang, Jie Zhu, Mingqian Jiang, Ran Yang
  Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 4815.     CrossRef
• Risk factors for hypoglycaemia in adults with type 1 diabetes: a systematic review and meta-analysis
  Qiang Zhang, Haojie Zhou, Ruonan Lin, Liping Hu, Xiaoli Zhu
  BMC Endocrine Disorders.2025;[Epub]     CrossRef
• Adherence to the nutritional recommendations according to diabetes status in Korean adults: a cross-sectional study
  Jong Han Choi, Chen Lulu, Seon-Joo Park, Hae-Jeung Lee
  BMC Public Health.2024;[Epub]     CrossRef
• 당뇨병 치료의 진화: 관해를 향해가는 혁신적 약물치료와 첨단 관리기기의 결합
  종한 최, 민경 문
  Public Health Weekly Report.2024; 17(44): 1905.     CrossRef
• The Impact of the Dietary Inflammatory Index, Fasting Blood Glucose, and Smoking Status on the Incidence and Survival of Pancreatic Cancer: A Retrospective Case–Control Study and a Prospective Study
  Ga Hyun Lee, Yeon Hee Kim, Sang Myung Woo, Woo Jin Lee, Sung-Sik Han, Sang-Jae Park, Sherry Price, Penias Tembo, James R. Hébert, Mi Kyung Kim
  Nutrients.2024; 16(22): 3941.     CrossRef
• Enhancing Large Language Model Reliability: Minimizing Hallucinations with Dual Retrieval-Augmented Generation Based on the Latest Diabetes Guidelines
  Jaedong Lee, Hyosoung Cha, Yul Hwangbo, Wonjoong Cheon
  Journal of Personalized Medicine.2024; 14(12): 1131.     CrossRef
• High-Intensity Interval Training and Diabetes
  Yunjung Cho, Eun Sook Kim
  The Journal of Korean Diabetes.2024; 25(4): 224.     CrossRef
• SIGNIFICANCE OF URINARY AMINOPEPTIDASE N AND DIPEPTIDYL PEPTIDASE IV IN EARLY DIAGNOSIS OF KIDNEY DAMAGE IN CHILDREN WITH TYPE 1 DIABETES MELLITUS IN NORTH-EASTERN REGION OF UKRAINE
  Iryna Vikhrova, Andrii Loboda, Igor Zmyslia
  Eastern Ukrainian Medical Journal.2024; 12(4): 808.     CrossRef

Citations

Citations to this article as recorded by  

• Sodium‐glucose cotransporter 2 inhibitor ameliorates thiazolidinedione‐induced fluid retention through vascular leakage reduction in white adipose tissue
  Ji Yoon Kim, Hye‐Min Jang, Hye‐Jin Lee, Ah Hyeon Lee, Dong‐Hoon Kim, Sin Gon Kim, Nam Hoon Kim
  Diabetes, Obesity and Metabolism.2026; 28(3): 1764.     CrossRef
• A chalcone-rich extract from licorice root inhibits liver steatosis and fibrosis via regulating PPARα and TGFβ signaling
  Ying Tang, Baibo Xie, Yuqing Zhang, Shi Li, Haifeng Liu, Bojun Wang, Xiaohong Ye, Hu Zhou, James Hua Zhou
  Phytomedicine.2026; 151: 157749.     CrossRef
• Nutritional composition, phytochemistry, and mechanistic insights into the health-promoting properties of Termitomyces robustus: A comprehensive review
  Uche O. Arunsi, Eziuche A. Ugbogu, Chollom L. Israel, Victor C. Nwankwo, Chinonye C. Arunsi, Daniel C. Ezirim, Ahmad Altayyar, Tuba Esatbeyoglu, Solomon Owumi
  Journal of Food Composition and Analysis.2026; 150: 108903.     CrossRef
• Insights into the Chemistry, Pharmacokinetics and Analytical Techniques of Lobeglitazone: A Novel Anti-diabetic Drug
  Saradhkumar Mudaliar, Nandan Godani, Sanjay Sharma
  Current Analytical Chemistry.2026; 22(2): 185.     CrossRef
• Molecular insights into PPAR-γ: genetic variations exploring association with diabetes and related complications and their role in antidiabetic drug response— A comprehensive review
  Sunaina Gautam, Shivani Kumari, Deepika Misra, Naveen Kumar Gautam
  International Journal of Diabetes in Developing Countries.2026;[Epub]     CrossRef
• Primary cardiovascular preventive effect of thiazolidinedione in adults with type 2 diabetes: A nationwide cohort study in Korea
  Yun Young Choi, Jimin Jeon, Minyoul Baik, Joonsang Yoo, Jinkwon Kim
  Journal of Diabetes Investigation.2026; 17(8): 1367.     CrossRef
• Cardiovascular preventive role of thiazolidinedione in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention
  Jinkwon Kim, Jimin Jeon, Joonsang Yoo, Minyoul Baik, Seok‐Jae Heo, Ji Woong Roh
  Journal of Diabetes Investigation.2026;[Epub]     CrossRef
• Shifting the Paradigm in Global Diabetes Management: Beyond Glycohemoglobinism and Toward Etiological Mitigation via Minimizing Insulin Resistance on the Basis of Pharmacogenetics
  Sidhartha D. Ray, Lining Liang He, Stratton Rottersmann, Christina Hand, Maria Di Leo, Alec Chunilall, Ian G. Gray, Ngo Tsun Siu, Sonia Jong, Nigel Sirois, Kaitlin M. McNeely, Margarett A. Costes
  Diabetology.2026; 7(9): 176.     CrossRef
• Identification of Novel Organo-Se BTSA-Based Derivatives as Potent, Reversible, and Selective PPARγ Covalent Modulators for Antidiabetic Drug Discovery
  Fangyuan Chen, Qingmei Liu, Lei Ma, Cuishi Yan, Haiman Zhang, Zhi Zhou, Wei Yi
  Journal of Medicinal Chemistry.2025; 68(1): 819.     CrossRef
• The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke
  Nada H. Aljarba, Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Mustafa M. Shokr, Marios Papadakis, Athanasios Alexiou, Mubarak Alruwaili, Mohammed Alrouji, Mohammed S. Alshammari, Gaber El-Saber Batiha
  Brain Research Bulletin.2025; 222: 111236.     CrossRef
• Peroxisome proliferator-activated receptors (PPARs) agonists as promising neurotherapeutics
  Iman A.Y. Ghannam, Rasha M. Hassan, Mohammed S. Abdel-Maksoud
  Bioorganic Chemistry.2025; 156: 108226.     CrossRef
• The Many Facets of PPAR-γ Agonism in Obesity and Associated Comorbidities: Benefits, Risks, Challenges, and Future Directions
  Dimitris Kounatidis, Natalia G. Vallianou, Eleni Rebelos, Marina Kouveletsou, Paraskevi Kontrafouri, Ioanna Eleftheriadou, Evanthia Diakoumopoulou, Irene Karampela, Nikolaos Tentolouris, Maria Dalamaga
  Current Obesity Reports.2025;[Epub]     CrossRef
• Drugs targeting peroxisome proliferator-activated receptors
  Zhouling Xie, Jiwei Xin, Chuping Huang, Chenzhong Liao
  Drug Discovery Today.2025; 30(3): 104318.     CrossRef
• Characterization of Forced Degradation Products of Lobeglitazone Sulfate by Liquid Chromatography–Tandem Mass Spectrometry and In Silico Toxicity Study—Development and Validation of Stability‐Indicating Reverse Phase Liquid Chromatographic Method
  Chandrakant Bonde, Hemant Kumar Tatapudi, Ritik Nikam, Smita Bonde, Ritesh Bhole
  SEPARATION SCIENCE PLUS.2025;[Epub]     CrossRef
• Molecular Docking, Pharmacophore Modeling and ADMET Prediction of Novel Heterocyclic Leads as Glucokinase Activators
  Anuradha Mehra, Amit Mittal, Shivangi Singh
  Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry.2025; 24(1): 57.     CrossRef
• Development and Validation of QBD-Assisted Using Central Composite Design RP-HPLC Method for Lobeglitazone Sulfate and Glimipiride in Bulk and Its Combined Dosage Form
  A. Marina Juliet, Punniyakoti Veeraveedu Thanikachalam
  Chromatographia.2025; 88(5): 381.     CrossRef
• Thiazolidinedione Use and Cardiovascular Outcomes in Patients With Type 2 Diabetes Who Underwent Carotid Artery Revascularization
  Jun Hwee Kim, Jimin Jeon, Seok‐Jae Heo, Tae‐Jin Song, Minyoul Baik, Joonsang Yoo, Jinkwon Kim
  Journal of the American Heart Association.2025;[Epub]     CrossRef
• Glabridin Alleviates Metabolic Disorders in Diet‐Induced Diabetic Mice
  Xiaoxue Yang, Kaiyi Lai, Jiayu Zhang, Ziyi Chen, Wenwen Ding, Yu Jiang, Ying Liu
  Phytotherapy Research.2025; 39(12): 5551.     CrossRef
• Discovery of a novel binding pocket in PPARγ for partial agonists: structure-based virtual screening identifies ginsenoside Rg5 as a partial agonist promoting beige adipogenesis
  Zhen Wang, Kexin Shui, Zehui Zhang, Yihan Chen, Nanfei Yang, Shiliang Ji, Pingping Shen, Qiang Tian
  Frontiers in Chemistry.2025;[Epub]     CrossRef
• Recent achievements in molecular insights, anticancer activities, and comparative structure activity relationships of thiazolidin-4-one derivatives as EGFR inhibitors (2019-present)
  Wessam I. Elsisi, Riham F. George, Yasmin M. Syam, Gamal E.F. Abd-Ellatef, Somaia S. Abd El-Karim
  Bioorganic & Medicinal Chemistry.2025; 128: 118244.     CrossRef
• Mitophagy: A double-edged sword in tumor cell death regulation and therapeutic response
  Tong Chu, Zifeng Huang, Wenzhe Ma
  Biochemical and Biophysical Research Communications.2025; 777: 152254.     CrossRef
• Neuroprotective effect of the peroxisome proliferator-activated receptor γ agonist lobeglitazone following intracerebral hemorrhage in rats
  Tae Jung Kim, Young-Ju Kim, Soo-Hyun Park, Youngjoon Kim, Sang-Bae Ko
  Molecular and Cellular Neuroscience.2025; 134: 104030.     CrossRef
• Greenness analysis of stability indicating RP-HPLC method for determination of lobeglitazone sulphate and glimepiride in tablets
  Aashiya Patel, Aesha Bhalodia, Sonal Desai, Suchi Desai, Yachita Jokhi, Megha Shah
  Discover Chemistry.2025;[Epub]     CrossRef
• Stress testing study, stability indicating analytical method development and degradant characterization using LC-MS for lobeglitazone
  Vinod Rajaram Jejurkar, Charushila Jayant Bhangale
  Microchemical Journal.2025; 218: 115331.     CrossRef
• ENHANCED BIOAVAILABILITY OF LOBEGLITAZONE VIA DISSOLVING MICRONEEDLE PATCHES IN RATS
  SUKANTA ROY, BALARAM GHOSH, ANANYA CHANDRA, DIBYA DAS, PARAG GHOSH, SANGEETA CHOUDHURY, ANIRBANDEEP BOSE, SUBAS CHANDRA DINDA
  International Journal of Applied Pharmaceutics.2025; : 488.     CrossRef
• Decades old glitazones still find niche in drug discoveries as PPAR-γ agonists: medicinal chemistry perspective, structure-activity relationships and therapeutic implications
  P. Archana, T. Durai Ananda Kumar, N. Vijaya Ganesh, Manal Mohammed, Harshal Pundalik Tavanoji, R. Deepikarani, B.R. Prashantha Kumar
  Bioorganic & Medicinal Chemistry.2025; 131: 118393.     CrossRef
• Is Predisposition to T2D Impacted by Polymorphisms in Genes Involved in Insulin Signaling and Cellular Bioenergetics?
  Benudhara Pati, Martin Jastroch, Naresh Chandra Bal
  Acta Physiologica.2025;[Epub]     CrossRef
• A Robust High-performance Thin-layer Chromatographic Method for the precise quantification of Lobeglitazone sulfate in Tablet Formulation
  Dhanya B. Sen, Krunal Baldha, Ashim Kumar Sen, Rajesh A. Maheshwari, Aarti S. Zanwar, Rahul Raval, Manojkumar K. Munde
  Research Journal of Pharmacy and Technology.2025; : 4695.     CrossRef
• Recent advances in the design, development and therapeutic applications of PPARγ agonists
  Iman A. Y. Ghannam, Heba T. Abdel-Mohsen, Islam H. Ali
  Future Medicinal Chemistry.2025; 17(22): 2751.     CrossRef
• Mercury-induced neurotoxicity in rat: in vivo and in silico studies of thymoquinone modulatory effect via oxidative stress and inflammation, HO-1/NRF/Trx/Trx-R trajectories
  Solomon Owumi, Moses Otunla, Jesutosin O. Babalola, Uche Arunsi, Chioma E. Irozuru, Ahmad Altayyar, Olatunde Owoeye
  BMC Veterinary Research.2025;[Epub]     CrossRef
• Thiazolidinediones: Recent Development in Analytical Methodologies
  Tarang Patel, Vatsal Patel
  Journal of Chromatographic Science.2024; 62(8): 789.     CrossRef
• Etiology of Drug-Induced Edema: A Review of Dihydropyridine, Thiazolidinedione, and Other Medications Causing Edema
  Evan S Sinnathamby, Bretton T Urban, Robert A Clark, Logan T Roberts, Audrey J De Witt, Danielle M Wenger, Aya Mouhaffel, Olga Willett, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D Kaye, Giustino Varrassi
  Cureus.2024;[Epub]     CrossRef
• Novel thiazolidin-4-one benzenesulfonamide hybrids as PPARγ agonists: Design, synthesis and in vivo anti-diabetic evaluation
  Islam H. Ali, Rasha M. Hassan, Ahmed M. El Kerdawy, Mahmoud T. Abo-Elfadl, Heba M.I. Abdallah, Francesca Sciandra, Iman A.Y. Ghannam
  European Journal of Medicinal Chemistry.2024; 269: 116279.     CrossRef
• The role of the methoxy group in approved drugs
  Debora Chiodi, Yoshihiro Ishihara
  European Journal of Medicinal Chemistry.2024; 273: 116364.     CrossRef
• Thiazolidinedione an auspicious scaffold as PPAR-γ agonist: its possible mechanism to Manoeuvre against insulin resistant diabetes mellitus
  Sourav Basak, Anjali Murmu, Balaji Wamanrao Matore, Partha Pratim Roy, Jagadish Singh
  European Journal of Medicinal Chemistry Reports.2024; 11: 100160.     CrossRef
• Quantitative determination of lobeglitazone sulfate and glimepiride in combined tablet by robust high‐performance thin layer chromatographic method
  Ashim Kumar Sen, Tantul Sarkar, Dhanya B. Sen, Rajesh A. Maheshwari, Aarti S. Zanwar, Rajesh L. Dumpala
  SEPARATION SCIENCE PLUS.2024;[Epub]     CrossRef
• A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties
  Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Roberta Montanari, Davide Capelli, Judith Wackerlig, Stefan Simic, Emanuele Falbo, Lucia Pecora, Rosalba Leuci, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Abanish Biswas, Ravi Pratap Singh, Su
  European Journal of Medicinal Chemistry.2024; 275: 116567.     CrossRef
• Synchronized Assessment of Lobeglitazone Sulfate and Metformin Hydrochloride in Tablet by Robust, High-performance Thin-layer Chromatographic Method
  Dhanya B. Sen, Krunal Baldha, Ashim K. Sen, Rajesh A. Maheshwari, Aarti S. Zanwar, Greeshma K. P., Prasanna K. Pradhan
  Current Pharmaceutical Analysis.2024; 20(5): 345.     CrossRef
• Recent Advances in the Treatment of Diabetes in the Elderly
  Ha-Kyoung Park, Hun-Sung Kim
  Korean Journal of Geriatrics & Gerontology.2024; 25(3): 129.     CrossRef
• Efficacy and Safety of Novel Thiazolidinedione Rivoglitazone in Type-2 Diabetes a Meta-Analysis
  Deep Dutta, Jyoti Kadian, Indira Maisnam, Ashok Kumar, Saptarshi Bhattacharya, Meha Sharma
  Indian Journal of Endocrinology and Metabolism.2023; 27(4): 286.     CrossRef
• Efficacy and safety of novel thiazolidinedione lobeglitazone for managing type-2 diabetes a meta-analysis
  Deep Dutta, Saptarshi Bhattacharya, Manoj Kumar, Priyankar K. Datta, Ritin Mohindra, Meha Sharma
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(1): 102697.     CrossRef
• Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis
  Shashank R. Joshi, Saibal Das, Suja Xaviar, Shambo Samrat Samajdar, Indranil Saha, Sougata Sarkar, Shatavisa Mukherjee, Santanu Kumar Tripathi, Jyotirmoy Pal, Nandini Chatterjee
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(1): 102703.     CrossRef
• Synthesis, Characterization, and Pharmacokinetic Studies of Thiazolidine-2,4-Dione Derivatives
  Bushra Ansari, Haroon Khan, Muhammad Saeed Jan, Khalaf F. Alsharif, Khalid J. Alzahrani, Umer Rashid, Abdul Saboor Pirzada, Vinod Kumar Tiwari
  Journal of Chemistry.2023; 2023: 1.     CrossRef
• Will lobeglitazone rival pioglitazone? A systematic review and critical appraisal
  Kalyan Kumar Gangopadhyay, Awadhesh Kumar Singh
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(4): 102747.     CrossRef
• Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects
  Heeyoung Kim, Choon Ok Kim, Hyeonsoo Park, Min Soo Park, Dasohm Kim, Taegon Hong, Yesong Shin, Byung Hak Jin
  Translational and Clinical Pharmacology.2023; 31(1): 59.     CrossRef
• Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
  Joonsang Yoo, Jimin Jeon, Minyoul Baik, Jinkwon Kim
  Cardiovascular Diabetology.2023;[Epub]     CrossRef
• Complementary effects of dapagliflozin and lobeglitazone on metabolism in a diet-induced obese mouse model
  Yun Kyung Lee, Tae Jung Oh, Ji In Lee, Bo Yoon Choi, Hyen Chung Cho, Hak Chul Jang, Sung Hee Choi
  European Journal of Pharmacology.2023; 957: 175946.     CrossRef
• Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease
  Shotaro Kamata, Akihiro Honda, Isao Ishii
  Biomolecules.2023; 13(8): 1264.     CrossRef
• Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver
  Hye-Young Seo, So-Hee Lee, Ji Yeon Park, Eugene Han, Sol Han, Jae Seok Hwang, Mi Kyung Kim, Byoung Kuk Jang, Kenji Fujiwara
  PLOS ONE.2023; 18(8): e0290532.     CrossRef
• Insulin sensitizers in 2023: lessons learned and new avenues for investigation
  Jerry R. Colca, Steven P. Tanis, Rolf F. Kletzien, Brian N. Finck
  Expert Opinion on Investigational Drugs.2023; 32(9): 803.     CrossRef
• Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach
  Priyamvada Amol Arte, Kanchanlata Tungare, Mustansir Bhori, Renitta Jobby, Jyotirmoi Aich
  Human Cell.2023; 37(1): 54.     CrossRef
• Lobeglitazone and Its Therapeutic Benefits: A Review
  Balamurugan M, Sarumathy S, Robinson R
  Cureus.2023;[Epub]     CrossRef
• Diabetes and diabesity in the view of proteomics, drug, and plant-derived remedies
  Mohammad Reza Haeri
  Journal of Research in Medical Sciences.2023;[Epub]     CrossRef
• A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study
  Soree Ryang, Sang Soo Kim, Ji Cheol Bae, Ji Min Han, Su Kyoung Kwon, Young Il Kim, Il Seong Nam‐Goong, Eun Sook Kim, Mi‐kyung Kim, Chang Won Lee, Soyeon Yoo, Gwanpyo Koh, Min Jeong Kwon, Jeong Hyun Park, In Joo Kim
  Diabetes, Obesity and Metabolism.2022; 24(9): 1800.     CrossRef
• Effect of the addition of thiazolidinedione to sodium-glucose cotransporter 2 inhibitor therapy on lipid levels in type 2 diabetes mellitus: a retrospective study using Korean National Health Insurance Service data
  Taegyun Park, Kyungdo Han, Dongwook Shin, Jongho Park
  Cardiovascular Prevention and Pharmacotherapy.2022; 4(3): 114.     CrossRef
• Design of Improved Antidiabetic Drugs: A Journey from Single to Multitarget Agents
  Vassiliki‐Panagiota Tassopoulou, Ariadni Tzara, Angeliki P. Kourounakis
  ChemMedChem.2022;[Epub]     CrossRef
• A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus
  Bo-Yeon Kim, Hyuk-Sang Kwon, Suk Kyeong Kim, Jung-Hyun Noh, Cheol-Young Park, Hyeong-Kyu Park, Kee-Ho Song, Jong Chul Won, Jae Myung Yu, Mi Young Lee, Jae Hyuk Lee, Soo Lim, Sung Wan Chun, In-Kyung Jeong, Choon Hee Chung, Seung Jin Han, Hee-Seok Kim, Ju-Y
  Diabetes & Metabolism Journal.2022; 46(6): 855.     CrossRef
• Lobeglitazone Exerts Anti-Inflammatory Effect in Lipopolysaccharide-Induced Bone-Marrow Derived Macrophages
  Dabin Jeong, Wan-Kyu Ko, Seong-Jun Kim, Gong-Ho Han, Daye Lee, Seung-Hun Sheen, Seil Sohn
  Biomedicines.2021; 9(10): 1432.     CrossRef

Citations

Citations to this article as recorded by  

• Limited Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Appetite and Body Weight: Evidence From Clinical and Rodent Studies
  Joonyub Lee, Sohee Park, Evonne Kim, Ji-Yeon Park, Marie Rhee, Jing W. Hughes, Seung-Hyun Ko, Obin Kwon, Eun Young Lee
  Journal of Korean Medical Science.2026;[Epub]     CrossRef
• Enavogliflozin, an SGLT2 Inhibitor, Improves Nonalcoholic Steatohepatitis Induced by High-Fat, High-Cholesterol Diet
  Phuc Thi Minh Pham, Giang Nguyen, So Young Park, Thuy Linh Lai, Dae-Hee Choi, Jeana Hong, Seon Mee Kang, Eun-Hee Cho
  Diabetes & Metabolism Journal.2026; 50(1): 165.     CrossRef
• GraphBAN-based identification of active ingredients and key gene targets in compound Chinese herbal medicines for polycystic ovary syndrome
  Shiyang Wei, Ting Qin, Ying Li, Daguo Zhang, Limin Liu, Liying Wei, Renfeng Zhao
  Naunyn-Schmiedeberg's Archives of Pharmacology.2026; 399(7): 9565.     CrossRef
• Empagliflozin Alleviates Arsenic Trioxide–Induced Nephrotoxicity by Activating the SIRT1/Akt/Nrf2 Pathway
  Chunrong Pang, Wenlei Zhang, Chenli Yue, Haoxuan Li, Jinyan Li, Xinru Wang, Xinsheng Duan, Longyu Li, Zengliang Gao, Xin Hai, Phuping sucharitakul
  Journal of Toxicology.2026;[Epub]     CrossRef
• SGLT2 inhibitors and AMPK crosstalk in diabetes mellitus: mechanistic insights and therapeutic applications
  Kiavash Hushmandi, Navvabeh Salarizadeh, Behzad Einollahi, Morteza Izadi, Pardis Doosti, Mohammad Javad Behzadnia, William C. Cho, Tooba Yousefi, Seyedeh Mahdieh Khoshnazar, Mina Alimohammadi, Najma Farahani
  Journal of Diabetes & Metabolic Disorders.2026;[Epub]     CrossRef
• AMPK is dispensable for physiological podocyte and glomerular functions but prevents glomerular fibrosis in experimental diabetes
  Swayam Prakash Srivastava, Olivia Kopasz-Gemmen, Abhiram Kunamneni, Aaron Thurman, Shota Yoshida, Eden Ozkan, Vinamra Swaroop, Rahul Nanwani, Ajan Arora, Arya Joshi, Om Khuperkar, Mariam Hamed, Mihir Suresh Bharadwaj, Niloy Islam, Adesh Urval, Junying Wan
  Cell Death Discovery.2026;[Epub]     CrossRef
• Unlocking the therapeutic potential of canagliflozin in NAFLD: Insights into AMPK/SIRT1-mediated lipophagy
  Nahla E. El-Ashmawy, Ghada M. Al-Ashmawy, Asmaa A. Kamel, Eman G. Khedr
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(3): 167666.     CrossRef
• Lactucin and lactucopicrin ameliorate obesity in high-fat diet fed mice by promoting white adipose tissue browning through the activation of the AMPK/SIRT1/PGC-1α pathway
  Yewei Zhong, Junlin Yan, Yi Lei, Rui Zhang, Adalaiti Abudurexiti, Shuwen Qi, Wenhui Hou, Xiaoli Ma
  The Journal of Nutritional Biochemistry.2025; 139: 109851.     CrossRef
• Sodium-Glucose Transporter-2 Inhibitors (SGLT2i) and Myocardial Ischemia: Another Compelling Reason to Consider These Agents Regardless of Diabetes
  Francesco Piccirillo, Matteo Lanciotti, Annunziata Nusca, Lorenzo Frau, Agostino Spanò, Paola Liporace, Gian Paolo Ussia, Francesco Grigioni
  International Journal of Molecular Sciences.2025; 26(5): 2103.     CrossRef
• Effect of Empagliflozin on Serum Levels of Thyroid Hormones Among Prediabetic and Diabetic Patients
  Mojgan Sanjari, Narges Sadeghi, Ladan Amirkhosravi, Mohammad Hadavizadeh, Ahmad Naghibzadeh-Tahami, Zohreh Safi, Suraiya Saleem
  International Journal of Endocrinology.2025;[Epub]     CrossRef
• SGLT2 Inhibition by Enavogliflozin Significantly Reduces Aβ Pathology and Restores Cognitive Function via Upregulation of Microglial AMPK Signaling in 5XFAD Mouse Model of Alzheimer's Disease
  Jihui Han, Jaehoon Song, Eun Sun Jung, Ji Won Choi, Hye Young Ji, Inhee Mook‐Jung
  Aging Cell.2025;[Epub]     CrossRef
• Physiological Conditions, Bioactive Ingredients, and Drugs Stimulating Non-Shivering Thermogenesis as a Promising Treatment Against Diabesity
  Diego Salagre, Ciskey V. Ayala-Mosqueda, Samira Aouichat, Ahmad Agil
  Pharmaceuticals.2025; 18(9): 1247.     CrossRef
• The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
  Milton Packer
  JACC.2025; 86(16): 1269.     CrossRef
• Beyond the Cardio–Renal–Metabolic Axis: Emerging Therapeutic Targets and Novel Mechanisms of Action of Flozins
  Wojciech Matuszewski, Lena Tomaszek, Michał Szklarz, Jan Marek Górny, Bernard Kordas, Joanna Rutkowska, Judyta Juranek
  Journal of Clinical Medicine.2025; 14(18): 6348.     CrossRef
• Is Type 2 Diabetes a Modifiable Risk Factor for the Evolution and Progression of Heart Failure With a Preserved Ejection Fraction?
  Milton Packer, Carolyn S.P. Lam, Javed Butler, Faiez Zannad, Muthiah Vaduganathan, Barry A. Borlaug
  JACC.2025; 86(20): 1917.     CrossRef
• Rationale and design of the Adipose Dysfunction, Imaging, Physiology, and Outcomes with sodium-glucose cotransporter − 2 inhibitors for Sleep Apnea (ADIPOSA) study
  Ehimen Aneni, Isaac Karim, Joe Rutter, Opemipo Olaseni, Iouri Kreinin, Sui Tsang, Zuoheng Wang, Kingman P. Strohl, H. Klar Yaggi, Ian J. Neeland
  Contemporary Clinical Trials.2025; 159: 108134.     CrossRef
• Extracellular vesicle miR-425-5p promotes visceral fat reduction via DACT1 suppression in SGLT2i-treated diabetes
  Jae-Hyung Park, Thi Nhi Nguyen, Hye Min Shim, Yun-Ui Bae, Gyeong Im Yu, Junho Kang, Eun Yeong Ha, Hochan Cho
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• SGLT2 Inhibitors as Systemic Metabolic Modulators: Linking Glucose Excretion to Liver Function Restoration
  Seung Wan Noh, Han Sol Ryu, Yong-Ho Kim, Byung-Chul Oh
  Endocrinology and Metabolism.2025; 40(6): 851.     CrossRef
• SGLT2 inhibitors and AMPK: The road to cellular housekeeping?
  Nasser Safaie, Shahab Masoumi, Shaban Alizadeh, Pourya Mirzajanzadeh, Hamid Reza Nejabati, Mobasher Hajiabbasi, Vahid Alivirdiloo, Neda Chobdari Basmenji, Aysan Derakhshi Radvar, Ziba Majidi, Yousef Faridvand
  Cell Biochemistry and Function.2024;[Epub]     CrossRef
• Proximal tubule hypertrophy and hyperfunction: a novel pathophysiological feature in disease states
  Mehmet Kanbay, Sidar Copur, Mustafa Guldan, Lasin Ozbek, Alper Hatipoglu, Adrian Covic, Francesca Mallamaci, Carmine Zoccali
  Clinical Kidney Journal.2024;[Epub]     CrossRef
• Mechanisms of SGLT2 Inhibitors in Heart Failure and Their Clinical Value
  Yafei Xie, Yujie Wei, Dan Li, Jie Pu, Hong Ding, Xiaowei Zhang
  Journal of Cardiovascular Pharmacology.2023; 81(1): 4.     CrossRef
• Current Treatment Options, Including Diet, Exercise, and Medications
  Mazen Noureddin, Manal F. Abdelmalek
  Clinics in Liver Disease.2023; 27(2): 397.     CrossRef
• SGLT2 Inhibitors and Kidney Diseases: A Clinical Perspective
  Panagiotis Theofilis, Rigas G. Kalaitzidis
  Current Medicinal Chemistry.2023; 30(23): 2595.     CrossRef
• Treatment of obesity-related diabetes: significance of thermogenic adipose tissue and targetable receptors
  Ruping Pan, Jiadai Liu, Yong Chen
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
  Ema Schönberger, Vjera Mihaljević, Kristina Steiner, Sandra Šarić, Tomislav Kurevija, Ljiljana Trtica Majnarić, Ines Bilić Ćurčić, Silvija Canecki-Varžić
  International Journal of Environmental Research and Public Health.2023; 20(17): 6671.     CrossRef
• SGLT‐2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model
  Manal Moustafa Mahmoud, Laila Ahmed Rashed, Somia Abdulatif Soliman, Safaa Mostafa Sayed, Omneya Kamel, Samaa Samir Kamar, Rania El Sayed Hussien
  Physiological Reports.2023;[Epub]     CrossRef
• Resting energy expenditure based on equation estimation can predict renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease
  Xiang Xiao, Shuming Ji, Junlin Zhang, Deying Kang, Fang Liu
  Renal Failure.2023;[Epub]     CrossRef
• Sodium-glucose Cotransporter 2 Inhibitors and Pathological Myocardial Hypertrophy
  Zhicheng Gao, Jiaqi Bao, Yilan Hu, Junjie Tu, Lifang Ye, Lihong Wang
  Current Drug Targets.2023; 24(13): 1009.     CrossRef
• SIRT1 mediates the inhibitory effect of Dapagliflozin on EndMT by inhibiting the acetylation of endothelium Notch1
  Weijie Wang, Yilan Li, Yanxiu Zhang, Tao Ye, Kui Wang, Shuijie Li, Yao Zhang
  Cardiovascular Diabetology.2023;[Epub]     CrossRef
• Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1/MAPK signaling
  Ke Lin, Na Yang, Wu Luo, Jin-fu Qian, Wei-wei Zhu, Shi-ju Ye, Chen-xin Yuan, Di-yun Xu, Guang Liang, Wei-jian Huang, Pei-ren Shan
  Acta Pharmacologica Sinica.2022; 43(10): 2624.     CrossRef
• Pleiotropic effects of SGLT2 inhibitors and heart failure outcomes
  Panagiotis Theofilis, Marios Sagris, Evangelos Oikonomou, Alexios S. Antonopoulos, Gerasimos Siasos, Kostas Tsioufis, Dimitris Tousoulis
  Diabetes Research and Clinical Practice.2022; 188: 109927.     CrossRef
• Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models
  Sandra Feijóo-Bandín, Alana Aragón-Herrera, Manuel Otero-Santiago, Laura Anido-Varela, Sandra Moraña-Fernández, Estefanía Tarazón, Esther Roselló-Lletí, Manuel Portolés, Oreste Gualillo, José Ramón González-Juanatey, Francisca Lago
  International Journal of Molecular Sciences.2022; 23(10): 5634.     CrossRef
• Potential molecular mechanism of action of sodium-glucose co-transporter 2 inhibitors in the prevention and management of diabetic retinopathy
  Lia Meuthia Zaini, Arief S Kartasasmita, Tjahjono D Gondhowiardjo, Maimun Syukri, Ronny Lesmana
  Expert Review of Ophthalmology.2022; 17(3): 199.     CrossRef
• New insights and advances of sodium-glucose cotransporter 2 inhibitors in heart failure
  Juexing Li, Lei Zhou, Hui Gong
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis
  Milton Packer
  Circulation.2022; 146(18): 1383.     CrossRef
• Nutraceutical activation of Sirt1: a review
  James J DiNicolantonio, Mark F McCarty, James H O'Keefe
  Open Heart.2022; 9(2): e002171.     CrossRef
• Dapagliflozin Restores Impaired Autophagy and Suppresses Inflammation in High Glucose-Treated HK-2 Cells
  Jing Xu, Munehiro Kitada, Yoshio Ogura, Haijie Liu, Daisuke Koya
  Cells.2021; 10(6): 1457.     CrossRef
• Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations
  Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Konstantinos E. Iliodromitis, Sotiria G. Giotaki, Charalampos Kossyvakis, Konstantinos Raisakis, Andreas Kaoukis, Vaia Lambadiari, Dimitrios Avramides, Bernhard Reimers, Giulio G. Stefanini, Michael C
  Drugs.2021; 81(12): 1381.     CrossRef
• Differential Pathophysiological Mechanisms in Heart Failure With a Reduced or Preserved Ejection Fraction in Diabetes
  Milton Packer
  JACC: Heart Failure.2021; 9(8): 535.     CrossRef
• Ketone bodies: from enemy to friend and guardian angel
  Hubert Kolb, Kerstin Kempf, Martin Röhling, Martina Lenzen-Schulte, Nanette C. Schloot, Stephan Martin
  BMC Medicine.2021;[Epub]     CrossRef